PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Plerixafor, a CXCR4 antagonist, mitigates skin radiation-induced injury in mice.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22799631 ↗2012Reported benefit

Plerixafor, a CXCR4 antagonist, mitigates skin radiation-induced injury in mice.

MouseRadiationC57BL/6Intraperitoneal5 mg/kgAdministration started on day 0, 4, 7, 15 or 24 after irradiation, with maximum…

Model: Radiation-induced skin injury produced by irradiation of the right hind leg; a 30 Gy exposure was used for the SDF-1 time-course measurements

Plerixafor improved both acute and late skin radiation responses, with the effect strongly dependent on timing of administration. Maximum benefit occurred when dosing started 1 week after irradiation, while earlier or later administration reduced efficacy. Cytokine levels and histologically assesse…

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.